Characterizing chlorotriazine effects in cancer-relevant high-throughput screening assays

Agnes L Karmaus1, Alex Charlton1

  • 1Syngenta Crop Protection, LLC, Greensboro, NC, United States.

Frontiers in Toxicology
|October 20, 2025
PubMed
Summary

High-throughput screening (HTS) identified potential cancer-related bioactivity in chlorotriazine herbicides by analyzing ToxCast/Tox21 data. Integrating in vitro results with in vivo evidence provides a framework for assessing carcinogenicity.

Related Concept Videos